Skip to main content

Interswitch Expands Presence in Health-Tech Space Through Acquisition of eClat

Interswitch Limited, a leading technology-driven company focused on the digitization of payments in Nigeria and other African countries, has announced the acquisition of eClat
Healthcare Limited, a Nigeria-based health technology company that aims to improve healthcare delivery in Africa.

The deal was completed on September 30, 2019, and it involves Interswitch acquiring a 60% stake in eClat through the purchase of shares from current shareholders and subscription to new shares issued by the company.

 Founded in 2012, eClat Healthcare Limited specializes in assisting healthcare service providers in planning, designing and operating their unique practices through the deployment of its bespoke healthcare technology platform, designed specifically for the healthcare environment in Africa. eClat’s healthcare technology platform, consists of a core e-Clinic software (including electronic billing, immunization, ante-natal and care pathway functions), as well as a variety of additional specialist modules. Prior to the acquisition, eClat’s platform had become a leading Electronic Health Record (EHR) platform used in over 250 public and private healthcare facilities in Nigeria.

Nigeria’s healthcare system currently lacks adequate funding and a national framework, leading to operational inefficiencies. Interswitch’s strategic investment in healthcare technology aims to address these challenges by modernising the healthcare sector in

Nigeria and eventually in Africa through its innovative products and services. The combined product offerings of Interswitch and eClat are expected to, amongst other things, enable operators in the healthcare sector develop new capabilities, improve the efficiency of their core operations and facilitate seamless payments.

Due to the growing adoption of Interswitch’s healthcare product offerings by the operators, Interswitch’s healthcare technology platform aims to be one of the top industry platforms in Nigeria, which can be utilised as a major data source by healthcare policy makers for planning and efficiency improvements in the sector.  As a result of this acquisition, the combined healthcare technology solutions are expected to position the Interswitch group as a health-tech solution and payments provider of choice to the healthcare industry going forward.

Commenting on the transaction, Mitchell Elegbe, Founder and Group Managing Director/Chief Executive Officer of Interswitch, said:

“We are a technology company that is innovating to deliver value across sectors that are critical to Africa’s social and economic development, our acquisition of eClat demonstrates strong progress along this strategy and alignment with our corporate vision.


Healthcare is rapidly evolving towards new, integrated and scalable models of care delivery that put the consumer at the centre.

At the core of Interswitch’s expansion into healthcare is our ambition to provide customers with greater access to healthcare across different interaction points beyond hospitals, such as at pharmacies and primary health care facilities, providing much needed services to patients across Nigeria and, in the future, in Africa.

 It also represents an opportunity to introduce a number of Interswitch’s products, such as our Verve Health cards, as well as our payment collection & disbursement solutions (Quickteller for business), that will drive much needed efficiency in payments for health services across the value chain”.

Also remarking on the acquisition, Dr. Wallace Ogufere, co-founder/CEO of eClat Healthcare Limited stated “The growing adoption of value-based care, combined with the increasing level of usage of patient portals across the industry, has made it critical to take a new approach to patient engagement solution design in Nigeria. We expect to tightly integrate the eClat capabilities into the Interswitch platform, adding functionality that would enable providers to reach their entire patient populations by leveraging existing patient contact information”.

This new acquisition by Interswitch represents the latest of several strategic investments executed by the company to enhance Interswitch’s product and service offering and expand its reach into new markets as the payments technology sector in Africa expands rapidly.


In 2016, Interswitch acquired the mobile financial services player, VANSO. Interswitch had earlier closed the acquisition of Paynet Group in February 2015 in a deal that resulted in the creation of a combined network of over 100 financial institutions, deepening Interswitch’s footprint in East Africa. Interswitch intends to continue with its expansion strategy whilst refining its offering, creating innovative payments solutions that are tailored to the demands of the African market. The acquisition of eClat Healthcare Limited is expected to further enhance Interswitch’s capability to provide comprehensive solutions that involve making payments a seamless part of everyday life across critical social sectors in Africa.  Further information: Edelman Public Relations Charles Harrison / Olivia Adebo +44 (0)203 047 2568
Interswitch@edelman.com
Mediacraft Associates Martha Okpeke +234 (0) 803 356 3795 isw.mediacraft@mediacraft.ng

Vaerdi Investor Relations
Oluyemisi Lanre-Phillips
+234 909 888 2196  Interswitch Group Tomi Ogunlesi Group Marketing & Corporate Communications gmcc@interswitchgroup.com +234 1 6283888 Ext 1253

Comments

Popular posts from this blog

PLASMODIASIS: WHAT YOU SHOULD KNOW?

TABLE OF CONTENTS Introduction Life circle of plasmodium Plasmodium in Erythrocytes  Female mosquitoes Species of plasmodium Symptoms of malaria Diagnosis and treatment. Prevention and control. Anti mosquitoes measure Vaccines and Research Plasmodiasis is a term that could be referred to a disorder of parasitic protozoan that is responsible for the breaking down of red blood cell  that gives rise to an infectious blood in the living system. This parasitic protozoan is called the plasmodium. The plasmodium thus released the sporozoites  and the merozoites into the blood stream and then transported to the liver and thus reduces the potency of the immune system. Life circle of plasmodium Malaria is a disease caused by a one-celled parasite known as Plasmodium. The parasite is transmitted to humans by the bite of the female Anopheles mosquito . The Plasmodium parasite spends its life cycle partly in humans and partly in mosquitoes. (A) Mosquito infected with the malaria par

Types Of Cancer

A n abnormal growth of the cell is defines what cancer is about, and this abnormal cell growth are most likely to attack other body part. There are more than hundred types of cancers that can affect man. One of the major cause of cancer is the use of tobacco, others are obesity, lack of nutritional diet, indiscriminate alcohol consumption. Another important cause of cancer is the onset of some diseases. Diseases like Hepatitis B, C and others can distort the genes of cells. One of the most effective way of preventing cancer is by shunning smoking, exercising, controlled alcohol consumption, eating more nutritional diet, early detection of cancerous. Below are the full compilation of the most common type of cancer: Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia, Childhood Adrenocortical Carcinoma Adrenocortical Carcinoma, Childhood AIDS-Related Cancers AIDS-Related Lymphoma A

Routes of Drug Administration

Table of Contents INTRODUCTION. DEFINITION. FACTORS OF DRUG ADMINISTRATION. ADVANTAGES AND DISADVANTAGES. CONCLUSION. Routes of medication administration To start, let’s talk about the different ways drugs can be administered. You’re probably familiar with injections and pills that you swallow, but medications can be given in many other ways as well. Routes of medication administration are described in the as follows…